Skip to main content

2-amino-9-B-D-arabinosyl-6-methoxy-9H-guanine (GW 506U; compound 506U) is highly active in patients with T-cell malignancies: Results of a phase I trial in pediatric and adult patients with refractory hematological malignancies.

Publication ,  Journal Article
Kurtzberg, J; Keating, M; Moore, JO; Gandhi, V; Blaney, S; Gold, S; Ernst, T; HensleeDowney, J; Chang, A; Kisor, D; Plunkett, W; Mitchell, B
Published in: BLOOD
November 15, 1996

Duke Scholars

Published In

BLOOD

ISSN

0006-4971

Publication Date

November 15, 1996

Volume

88

Issue

10

Start / End Page

2666 / 2666

Publisher

W B SAUNDERS CO

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kurtzberg J, Keating M, Moore JO, Gandhi V, Blaney S, Gold S, Ernst T, HensleeDowney J, Chang A, Kisor D, Plunkett W, Mitchell B. 2-amino-9-B-D-arabinosyl-6-methoxy-9H-guanine (GW 506U; compound 506U) is highly active in patients with T-cell malignancies: Results of a phase I trial in pediatric and adult patients with refractory hematological malignancies. BLOOD. W B SAUNDERS CO; 1996 Nov 15;88(10):2666–2666.

Published In

BLOOD

ISSN

0006-4971

Publication Date

November 15, 1996

Volume

88

Issue

10

Start / End Page

2666 / 2666

Publisher

W B SAUNDERS CO

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology